Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Mar 22 2000
WASHINGTON, DC (March 22, 2000) People benefiting from innovative biotechnology treatments against such diseases as rheumatoid arthritis, multiple sclerosis...
Mar 17 2000
WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and...
Mar 16 2000
WASHINGTON, DC (March 15, 2000) In response to the statement March 14 by President Bill Clinton and British Prime Minister Tony Blair and subsequent reaction...
Mar 14 2000
Washington, D.C., (March 14, 2000) -- BIO 2000 in Boston, March 26-30, will include the largest international contingent ever assembled for the annual...
Mar 14 2000
WASHINGTON, DC (March 14, 2000) The Biotechnology Industry Organization (BIO) issued the following response to the statement made today by President Bill...
Mar 10 2000
WASHINGTON, D.C. (March 10, 2000) The Biotechnology Industry Organization (BIO) applauded the National Institutes of Health Recombinant DNA Advisory Committee...
Mar 8 2000
WASHINGTON, D.C. (March 8, 2000) Nancy Myers, health care policy and reimbursement counsel of the Biotechnology Industry Organization (BIO), issued the...
Mar 7 2000
WASHINGTON, D.C. (March 7, 2000) BIO 2000 in Boston, March 26-30, will feature four days of scientific presentations examining the latest research on a...
Mar 7 2000
(Dr. Val Giddings, vice president for food and agriculture for BIO, today issued the following statement regarding USDA’s proposed new national organic...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...